NABRIVA THERAPEUTICS AG's ticker is NBRVXXXX and the CUSIP is 62957M104. A total of 20 filers reported holding NABRIVA THERAPEUTICS AG in Q2 2016. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $4,200,000 | +101.3% | 350,000 | 0.0% | 0.03% | +70.0% |
| Q4 2016 | $2,086,000 | -15.5% | 350,000 | 0.0% | 0.02% | -9.1% |
| Q3 2016 | $2,468,000 | -6.0% | 350,000 | 0.0% | 0.02% | -21.4% |
| Q2 2016 | $2,625,000 | -16.3% | 350,000 | 0.0% | 0.03% | -15.2% |
| Q1 2016 | $3,136,000 | -6.9% | 350,000 | 0.0% | 0.03% | +17.9% |
| Q4 2015 | $3,367,000 | +1.3% | 350,000 | 0.0% | 0.03% | -9.7% |
| Q3 2015 | $3,325,000 | – | 350,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|